Servei De Salut De Les Illes Balears

The Servicio de Neumología at Servei De Salut De Les Illes Balears is highly active in respiratory tract diseases, with studies focused on asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, pulmonary arterial hypertension, and other complex lung conditions. These trials are mainly designed to test new treatments, improve symptom control, and better understand how to reduce exacerbations and slow disease progression.

• Asthma, including eosinophilic and difficult-to-control forms
• Chronic obstructive pulmonary disease and chronic bronchitis
• Idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
• Pulmonary arterial hypertension and pulmonary hypertension linked to lung disease

Several studies also address severe pneumonia, bronchiectasis, and allergic airway disease, reflecting a strong focus on improving long-term respiratory care and treatment effectiveness in Palma.

This site conducts extensive research in neoplasms and hemic and lymphatic diseases, especially across breast cancer, non-small cell lung cancer, multiple myeloma, lymphoma, and leukemia. The trials commonly aim to evaluate newer therapies, compare treatment strategies, and improve outcomes for patients with advanced, relapsed, or high-risk cancers.

• Breast cancer, including HER2-positive, HR-positive, and triple-negative disease
• Non-small cell lung cancer, including KRAS-mutant and metastatic disease
• Multiple myeloma and myelodysplastic syndromes
• Acute and chronic leukemias, plus lymphoma subtypes

Research at Servei De Salut De Les Illes Balears also includes studies in ovarian, endometrial, prostate, renal, and colorectal cancers, showing a broad commitment to advancing cancer treatment across multiple tumor types.

Clinical trials in cardiovascular diseases at this hospital site focus on prevention, risk reduction, and better management of serious vascular conditions. Main areas include atherosclerotic cardiovascular disease, coronary artery disease, stroke, pulmonary embolism, and pulmonary arterial hypertension, with the goal of improving outcomes and reducing future events.

• Atherosclerotic cardiovascular disease and elevated lipoprotein(a)
• Acute ischemic stroke and transient ischemic attack
• Coronary disease and heart-related complications
• Pulmonary vascular disorders, including pulmonary arterial hypertension

Some studies also explore inherited heart conditions such as dilated cardiomyopathy, highlighting interest in early intervention and prevention before symptoms become severe.

Research in immune system diseases and skin and connective tissue diseases includes trials in atopic dermatitis, plaque psoriasis, hidradenitis suppurativa, systemic sclerosis-associated interstitial lung disease, and lupus nephritis. These studies are generally aimed at testing new options that may better control inflammation, reduce flares, and improve quality of life.

• Atopic dermatitis and psoriasis
• Hidradenitis suppurativa and other chronic inflammatory skin disorders
• Autoimmune and inflammatory conditions such as lupus nephritis and systemic sclerosis
• Immune-mediated lung and kidney complications

The site’s work in these areas reflects a strong interest in therapies that can provide more durable control of chronic immune-driven disease.

Trials in nutritional and metabolic diseases, hormonal diseases, and reproductive and urinary physiological phenomena cover diabetes, obesity, metabolic dysfunction-associated steatotic liver disease, chronic kidney disease, and glomerular disorders. The main purpose is to evaluate new treatments and better strategies for preventing complications in patients with long-term metabolic or renal illness.

• Type 2 diabetes, obesity, and related cardiovascular risk
• Chronic kidney disease, albuminuria, and end-stage kidney disease
• IgA nephropathy, lupus nephritis, and focal segmental glomerulosclerosis
• Fatty liver disease and other metabolic complications

These studies often focus on preserving organ function, reducing inflammation, and improving day-to-day disease control for patients with overlapping metabolic and kidney conditions.

The site also supports trials in virus diseases, bacterial infections, and related infectious conditions, including HIV, hepatitis B, latent tuberculosis infection, and bloodstream or device-related infections. The research is aimed at improving prevention, treatment effectiveness, and long-term infection control.

• HIV and HIV-1 infection
• Chronic hepatitis B
• Latent tuberculosis infection in high-risk patients
• Bacteremia and other serious bacterial infections

There is also interest in preventing infection-related complications in vulnerable groups, including patients with kidney disease, cancer, or implanted medical devices.

Clinical research at this site spans nervous system diseases and mental disorders, with studies in stroke, multiple sclerosis, Huntington disease, Alzheimer’s-related agitation, depression, and generalized anxiety disorder. The goal is to improve treatment response, symptom relief, and overall neurological or psychological functioning.

• Acute stroke and brain injury-related conditions
• Multiple sclerosis and other chronic neurologic disorders
• Depression, bipolar depression, and anxiety disorders
• Rare neurodegenerative and developmental conditions

These studies add breadth to the site’s portfolio by addressing both common and uncommon disorders that can significantly affect quality of life.